Title:
PYRIDINE DERIVATIVES AS IMMUNOMODULATORS
Document Type and Number:
WIPO Patent Application WO/2021/246781
Kind Code:
A1
Abstract:
Disclosed are pyridine derivatives of formula (I) and a pharmaceutical composition comprising the pyridine derivatives or their pharmaceutically acceptable salts or stereoisomers thereof, and at least one pharmaceutically acceptable carrier or excipient, which are useful as key intermediate for the synthesis of compounds to inhibit PD-1/PD-L1 signaling pathway or capable of inhibiting PD-1/PD-L1 signaling pathway.
Inventors:
CHUN KWANGWOO (KR)
KIM HYANGMI (KR)
CHOI YOUNG IL (KR)
KIM SOONNAM (KR)
SEO MIN JUNG (KR)
CHO HANYANG (KR)
KIM HYANGMI (KR)
CHOI YOUNG IL (KR)
KIM SOONNAM (KR)
SEO MIN JUNG (KR)
CHO HANYANG (KR)
Application Number:
PCT/KR2021/006886
Publication Date:
December 09, 2021
Filing Date:
June 02, 2021
Export Citation:
Assignee:
KAINOS MEDICINE INC (KR)
International Classes:
C07D405/14; A61K31/4412; A61K31/444; A61K45/06; A61P43/00; C07D213/64; C07D401/12; C07D405/12
Domestic Patent References:
| WO2019191624A1 | 2019-10-03 |
Foreign References:
| US20110281884A1 | 2011-11-17 | |||
| US20110166123A1 | 2011-07-07 |
Attorney, Agent or Firm:
FIRSTLAW P.C. (KR)
Download PDF: